Jan 17, 2026 08:00AM
Nov 20, 2025 08:00PM
Nov 20, 2025 08:00PM
Oct 31, 2025 09:20AM
Oct 30, 2025 11:02PM
Oct 30, 2025 11:02PM
Oct 14, 2025 08:00AM 4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
May 5, 2025 08:00AM
May 1, 2025 08:01AM
May 1, 2025 08:00AM
Mar 27, 2025 08:00AM
Feb 19, 2025 08:00AM
Feb 8, 2025 02:30PM
Jan 29, 2025 08:00AM 4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
Jan 10, 2025 08:07AM
Jan 10, 2025 08:00AM
Sep 19, 2024 08:06AM
Jun 8, 2024 04:30PM
Mar 28, 2024 01:32PM
Feb 7, 2024 05:33AM
Feb 7, 2024 05:21AM Goldman Sachs Reinstates 4D Molecular Therapeutics (FDMT) at Buy, 'Platform value to inflect via 2024 catalysts'
Feb 6, 2024 11:27PM
Feb 5, 2024 04:05PM
Feb 5, 2024 04:05PM
Feb 5, 2024 05:44AM
Feb 3, 2024 05:00PM
Jan 29, 2024 08:00AM
Jan 23, 2024 08:07AM 4DMT (FDMT) Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
Nov 9, 2023 04:19PM
Oct 30, 2023 08:01AM
Oct 30, 2023 08:00AM
Jul 31, 2023 05:41AM
Jul 29, 2023 12:00PM
Jul 10, 2023 07:30PM
Jul 5, 2023 05:35AM Chardan Capital Markets Starts 4D Molecular Therapeutics (FDMT) at Buy
Jun 7, 2023 04:10PM
Jun 7, 2023 04:10PM
Jun 1, 2023 08:00AM
May 11, 2023 08:00AM
May 11, 2023 08:00AM
May 9, 2023 04:05PM
May 8, 2023 04:05PM 4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
May 5, 2023 05:43AM
May 4, 2023 09:04PM
May 4, 2023 04:09PM
May 4, 2023 04:08PM
Apr 27, 2023 07:00AM
Apr 27, 2023 07:00AM
Apr 24, 2023 08:09AM Aevitas Therapeutics, a Fortress Biotech (FBIO) Subsidiary, Announces Asset Purchase Agreement with 4D Molecular Therapeutics for World-Wide Rights to Aevitas’ Short-Form Human Complement Factor H
Apr 24, 2023 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All